<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Commun Biol</journal-id><journal-id journal-id-type="iso-abbrev">Commun Biol</journal-id><journal-title-group><journal-title>Communications Biology</journal-title></journal-title-group><issn pub-type="epub">2399-3642</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">11252418</article-id><article-id pub-id-type="pmid">39014102</article-id>
<article-id pub-id-type="publisher-id">6559</article-id><article-id pub-id-type="doi">10.1038/s42003-024-06559-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Specific glycine-dependent enzyme motion determines the potency of conformation selective inhibitors of threonyl-tRNA synthetase</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Qiao</surname><given-names>Hang</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Wang</surname><given-names>Zilu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0008-0040-276X</contrib-id><name><surname>Yang</surname><given-names>Hao</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Xia</surname><given-names>Mingyu</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Guang</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1468-5568</contrib-id><name><surname>Bai</surname><given-names>Fang</given-names></name><address><email>baifang@shanghaitech.edu.cn</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7566-1212</contrib-id><name><surname>Wang</surname><given-names>Jing</given-names></name><address><email>JWang@sioc.ac.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3448-5494</contrib-id><name><surname>Fang</surname><given-names>Pengfei</given-names></name><address><email>FangPengfei@sioc.ac.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.410726.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1797 8419</institution-id><institution>State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, </institution><institution>University of Chinese Academy of Sciences, </institution></institution-wrap>200032 Shanghai, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/030bhh786</institution-id><institution-id institution-id-type="GRID">grid.440637.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 4657 8879</institution-id><institution>Shanghai Institute for Advanced Immunochemical Studies and School of Life Science and Technology, </institution><institution>ShanghaiTech University, </institution></institution-wrap>393 Middle Huaxia Road, 201210 Shanghai, China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qbk4x57</institution-id><institution-id institution-id-type="GRID">grid.410726.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1797 8419</institution-id><institution>School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, </institution><institution>1 Sub-lane Xiangshan, </institution></institution-wrap>310024 Hangzhou, China </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/030bhh786</institution-id><institution-id institution-id-type="GRID">grid.440637.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 4657 8879</institution-id><institution>School of Information Science and Technology, </institution><institution>ShanghaiTech University, </institution></institution-wrap>393 Middle Huaxia Road, 201210 Shanghai, China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.452344.0</institution-id><institution>Shanghai Clinical Research and Trial Center, </institution></institution-wrap>201210 Shanghai, China </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.484195.5</institution-id><institution>Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery, </institution></institution-wrap>510006 Guangzhou, China </aff></contrib-group><pub-date pub-type="epub"><day>16</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>16</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>7</volume><elocation-id>867</elocation-id><history><date date-type="received"><day>26</day><month>2</month><year>2024</year></date><date date-type="accepted"><day>5</day><month>7</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The function of proteins depends on their correct structure and proper dynamics. Understanding the dynamics of target proteins facilitates drug design and development. However, dynamic information is often hidden in the spatial structure of proteins. It is important but difficult to identify the specific residues that play a decisive role in protein dynamics. Here, we report that a critical glycine residue (Gly463) dominates the motion of threonyl-tRNA synthetase (ThrRS) and the sensitivity of the enzyme to antibiotics. Obafluorin (OB), a natural antibiotic, is a novel covalent inhibitor of ThrRS. The binding of OB induces a large conformational change in ThrRS. Through five crystal structures, biochemical and biophysical analyses, and computational simulations, we found that Gly463 plays an important role in the dynamics of ThrRS. Mutating this flexible residue into more rigid residues did not damage the enzyme&#x02019;s three-dimensional structure but significantly improved the thermal stability of the enzyme and suppressed its ability to change conformation. These mutations cause resistance of ThrRS to antibiotics that are conformationally selective, such as OB and borrelidin. This work not only elucidates the molecular mechanism of the self-resistance of OB-producing <italic>Pseudomonas fluorescens</italic> but also emphasizes the importance of backbone kinetics for aminoacyl-tRNA synthetase-targeting drug development.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">Crystal structures and molecular dynamics simulations reveal that a critical glycine residue dominates the motion of threonyl-tRNA synthetase and the sensitivity of the enzyme to conformation selective inhibitors.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Computational biophysics</kwd><kwd>Mechanism of action</kwd><kwd>Enzymes</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China (National Science Foundation of China)</institution></institution-wrap></funding-source><award-id>22277132, 22277134</award-id><principal-award-recipient><name><surname>Fang</surname><given-names>Pengfei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100012543</institution-id><institution>Shanghai Science and Technology Development Foundation (Shanghai Science and Technology Development Fund)</institution></institution-wrap></funding-source><award-id>22ZR1475000</award-id><principal-award-recipient><name><surname>Fang</surname><given-names>Pengfei</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Aminoacyl-tRNA synthetases (aaRSs) are key enzymes for protein translation in all cells, catalyzing the formation of an ester bond between a specific amino acid and the 3&#x02019;-end adenosine of its conjugate tRNA<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. There are three factors that make aaRSs valuable therapeutic targets. First, the sequence and fine structure differences between pathogenic microbial aaRS and human aaRS are applicable for designing drugs that selectively inhibit the pathogen aaRS<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. Second, only low levels of aaRSs are required for protein translation under physiological conditions, and cells are able to withstand the down-regulation of aaRSs; therefore, drugs that specifically target hyperproliferative cells, such as cancer cells, may be developed<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Third, some aaRSs have nonclassical functions associated with specific pathologies or cancers, making them potential targets for the development of novel pharmacological approaches<sup><xref ref-type="bibr" rid="CR6">6</xref>&#x02013;<xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par4">AaRSs present multiple druggable pockets, including amino acid- and ATP-binding sites, tRNA-binding regions, and other binding sites, such as editing sites and auxiliary hydrophobic pockets<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Competitive binding to these sites with substrate molecules is a common mechanism of action (MoA) for aaRS inhibitors, including single-site<sup><xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR15">15</xref></sup>, dual-site<sup><xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref></sup>, and recently developed triple-site inhibitors<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. In addition, inhibitors with novel MoAs, including Trojan horses<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref></sup>, induced-fit<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, and reaction hijacking inhibitors<sup><xref ref-type="bibr" rid="CR25">25</xref></sup> have been reported. These inhibitors are highly valuable for understanding the catalytic mechanism of aaRS and for developing therapeutic drugs that target aaRS.</p><p id="Par5">The natural product Obafluorin (OB) is a potent inhibitor of bacterial threonyl-tRNA synthetase (ThrRS)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. It is produced by <italic>Pseudomonas fluorescens</italic> ATCC 39502 through the nonribosomal peptide synthetase (NRPS) assembly line<sup><xref ref-type="bibr" rid="CR26">26</xref>&#x02013;<xref ref-type="bibr" rid="CR32">32</xref></sup>. The NRPS ObiF contains a type I thioesterase (TE) domain with a rarely reported cysteine residue at the catalytic site that plays a critical role in the formation of the OB <italic>&#x003b2;</italic>-lactone ring<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. OB has broad antibiotic activity against both Gram-positive and Gram-negative pathogens<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. The catechol moiety of OB was found to be essential for its antibacterial activity<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Our previous work showed that OB covalently binds to ThrRS, forming an ester bond with a tyrosine residue in the catalytic center via the highly strained <italic>&#x003b2;</italic>-lactone ring<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, making OB the first covalent aaRS inhibitor with demonstrated crystal structures.</p><p id="Par6">The elucidation of the self-resistance mechanisms of antibiotic-producing microorganisms will help to reveal the MoA of antibiotics, guide the discovery of new natural products, and provide key clues for clinical antibiotic resistance. The resistance of <italic>P. fluorescens</italic> to OB is related to the expression of ObaO, a second copy of ThrRS<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. However, why ObaO is resistant to OB remains unknown.</p><p id="Par7">During the analysis of the reason for the resistance of ObaO to OB, we found that a glycine residue involved in the formation of the active pocket of ThrRS contributes to the latter&#x02019;s sensitivity to OB. Through five crystal structures, biochemical and biophysical analyses, and computational simulations, we found that mutation of this flexible residue to a more rigid residue, such as a serine or an alanine, did not alter the structure, but significantly improved the thermal stability of the enzyme and suppressed the ability of ThrRS to change conformation. These mutations caused resistance of ThrRS to antibiotics that require conformational changes in ThrRS, including OB and another ThrRS inhibitor, borrelidin (BN). This work provides a deeper understanding of the MoA of OB and emphasizes the importance of backbone kinetics for drug development.</p></sec><sec id="Sec2" sec-type="results"><title>Results</title><sec id="Sec3"><title>Potential residues that cause OB resistance</title><p id="Par8">ObaO, the second ThrRS in <italic>P. fluorescens</italic>, exhibits partial resistance to OB (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Knockout of ObaO in <italic>P. fluorescens</italic> ATCC 39502 results in OB sensitivity, while expression of ObaO in OB-sensitive <italic>Escherichia coli</italic> strains confers resistance to OB<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. However, the structure of ObaO predicted by Alphafold<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> is very similar to that of <italic>E. coli</italic> ThrRS (<italic>Ec</italic>ThrRS, Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>). In particular, the residues that interact with <sc>l</sc>-Thr, ATP, and tRNA in <italic>Ec</italic>ThrRS and ObaO are 100% conserved<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. The reason why ObaO is resistant to OB is interesting. This immune protein is not only found in <italic>P. fluorescens</italic>, but also in <italic>Chitiniphilus shinanonensis</italic> and <italic>Burkholderia diffusa</italic>, which can produce OB in vivo<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref>). In the <italic>Ec</italic>ThrRS&#x02013;OB complex structure, 18 residues in the active center of ThrRS are located within 4.5&#x02009;&#x000c5; of the OB<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Among these residues, only Ala316 is substituted by an asparagine residue in the <italic>P. fluorescens</italic>, <italic>C. shinanonensis</italic>, and <italic>B. diffusa</italic> ObaO proteins. However, this substitution of alanine by asparagine also occurs in the <italic>P. fluorescens</italic>, <italic>C. shinanonensis</italic>, and <italic>B. diffusa</italic> housekeeping ThrRS proteins (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>). Using a thermal shift assay (TSA) and an ATP hydrolysis assay<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, we tested whether mutating Ala316 to asparagine would create OB resistance. Compound 36j, a substrate-competitive ThrRS inhibitor, was used as an experimental control<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">3</xref>). We have shown that the influence of OB on the thermal stability of ThrRS (or ThrRS mutants) is greater than or close to 36j when OB forms a covalent bond with the enzyme, and much less than that of 36j when OB cannot form a covalent bond with the enzyme<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. The TSA results showed that OB increased the mid-melting point (Tm) of <italic>Ec</italic>ThrRS_A316N by 33.4&#x02009;&#x000b0;C, which is slightly greater than that of 36j (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">4a</xref>). Consistently, the ATP hydrolysis assay showed that OB had a strong inhibitory effect on <italic>Ec</italic>ThrRS_A316N with an IC<sub>50</sub> value of 848&#x02009;nM (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">4b</xref>). Thus, the resistance of ObaO to OB is not due to the substitution of residues directly interacting with OB.<fig id="Fig1"><label>Fig. 1</label><caption><title>Sequence alignment and structural analysis suggested that some residues may lead to OB resistance.</title><p><bold>a</bold> Chemical structure of OB. <bold>b</bold> Superimposition of the structures of the catalytic domains of <italic>Ec</italic>ThrRS (gold, PDB code: 1EVK) and ObaO (white, predicted by AlphaFold). The RMSD is 0.740&#x02009;&#x000c5; over 280 C&#x003b1; atoms. <bold>c</bold> Sequence alignment of ThrRS homologs. The alignment was performed by <italic>Clustal Omega</italic> and processed with <italic>Jalview</italic>. The alignment of Ala316, Gly463 and Leu489 corresponding to <italic>Ec</italic>ThrRS are highlighted in red boxes. <bold>d</bold> Zoomed-in view of the catalytic pocket (blue cartoon) of <italic>Ec</italic>ThrRS bound to OB (orange sticks). Tyr462 is shown as green sticks. Gly463 and Leu489 are shown as yellow sticks.</p></caption><graphic xlink:href="42003_2024_6559_Fig1_HTML" id="d33e551"/></fig></p><p id="Par9">We therefore looked for the replacement of residues that might cause OB resistance in an expanded area in ObaO proteins. We noticed that Gly463 and Leu489 are two strictly conserved residues in the ThrRS proteins, but they are replaced by a serine and a methionine in the ObaOs, respectively (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">2</xref>). In particular, Gly463 is adjacent to Tyr462, which is the residue covalently bound to OB, and Leu489 is located within 7&#x02009;&#x000c5; of the OB in the pocket (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>). We postulated that the substitution of these two residues might prevent the binding of ObaO to OB or hinder the formation of the covalent bond between ObaO and OB.</p></sec><sec id="Sec4"><title>The glycine to serine substitution confers resistance of <italic>Ec</italic>ThrRS to OB</title><p id="Par10">We expressed and purified the G463S and L489M <italic>Ec</italic>ThrRS mutants to examine the effect of these two residue substitutions on OB resistance. We utilized TSA to preliminarily estimate the binding affinities of <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_L489M to OB. The results showed that 36j and OB increased the Tm of <italic>Ec</italic>ThrRS_L489M by 22.7&#x02009;&#x000b0;C and 22.6&#x02009;&#x000b0;C, respectively (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>), suggesting that OB strongly binds to <italic>Ec</italic>ThrRS_L489M, similar to 36j. In contrast, 36j increased the Tm of <italic>Ec</italic>ThrRS_G463S by 22.1&#x02009;&#x000b0;C while OB increased the Tm of <italic>Ec</italic>ThrRS_G463S by only 13.3&#x02009;&#x000b0;C (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a</xref>), suggesting that the binding affinity between OB and <italic>Ec</italic>ThrRS_G463S is much weaker than that between 36j and <italic>Ec</italic>ThrRS_G463S. These results suggest that the G463S mutation weakens the binding affinity of ThrRS for OB, while the L489M mutation does not. Next, we studied the inhibitory activity of OB against <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_L489M in an ATP hydrolysis assay. OB had a strong inhibitory effect on <italic>Ec</italic>ThrRS_L489M, with an IC<sub>50</sub> value of 215&#x02009;nM (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>). Therefore, the mutation of Leu489 to a methionine does not confer resistance of <italic>Ec</italic>ThrRS to OB. In contrast, OB showed poor activity against <italic>Ec</italic>ThrRS_G463S (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2b</xref>), with 5&#x02009;&#x003bc;M OB inhibiting only approximately 10% of the activity of <italic>Ec</italic>ThrRS_G463S, indicating that mutating Gly463 to a serine renders <italic>Ec</italic>ThrRS resistant to OB.<fig id="Fig2"><label>Fig. 2</label><caption><title>Ser463 confers the resistance of OB to <italic>Ec</italic>ThrRS rather than Met489.</title><p><bold>a</bold> Diagram of the &#x00394;Tm values of <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_L489M in the presence or absence of OB and 36j. Error bars represent the standard deviations (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;4, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). All the data points are shown as small circles. <bold>b</bold> Inhibitory curves of OB on the ATP hydrolysis activity of <italic>Ec</italic>ThrRS_G463S or <italic>Ec</italic>ThrRS_L489M. Error bars represent the standard deviations (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;4, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). All data points for EcThrRS_G463S and EcThrRS_L489M are shown as pink and green dots, respectively. <bold>c</bold> Superimposition of the structures of <italic>Ec</italic>ThrRS_WT&#x02013;OB (marine cartoons) and <italic>Ec</italic>ThrRS_L489M&#x02013;OB (green cartoons). The RMSD is 0.160&#x02009;&#x000c5; over 385 C&#x003b1; atoms. <bold>d</bold> Zoomed-in view of the catalytic pocket of <italic>Ec</italic>ThrRS_G463S, which was crystallized in the presence of OB. The 2Fo-Fc electron map (blue meshes contoured at 1.0 &#x003c3;) is shown together with the structure model. The Tyr462 residue and Ser463 residue are shown as green and cyan sticks, respectively. The OB binding site is circled with black dashed lines. In this state, the OB cannot form a covalent bond with Tyr462; hence, no density for the OB can be seen. The density of Tyr313 is also poor in this state.</p></caption><graphic xlink:href="42003_2024_6559_Fig2_HTML" id="d33e688"/></fig></p><p id="Par11">We confirmed this finding by crystallization experiments (Supplementary Tables&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref>). An <italic>Ec</italic>ThrRS_L489M&#x02013;OB complex structure was successfully obtained by cocrystallizing 300&#x02009;&#x003bc;M <italic>Ec</italic>ThrRS_L489M protein with 600&#x02009;&#x003bc;M OB (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">5</xref>). The conformation of <italic>Ec</italic>ThrRS_L489M was the same as that of the WT protein (PDB: 8H98) when both were in complex with OB (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>). Because in the OB-binding conformation, the active pocket has a larger opening<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, we refer to this state as the &#x0201c;open state&#x0201d;. The MoA of OB in <italic>Ec</italic>ThrRS_L489M remained consistent with what we found in <italic>Ec</italic>ThrRS_WT<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. In short, the <italic>&#x003b2;</italic>-lactone ring of OB opens and forms an ester bond with Tyr462; the <italic>o</italic>-diphenol group forms coordination bonds with the ThrRS conserved Zn<sup>2+</sup> ion; and the nitrobenzene group binds between Tyr313 and Arg363 (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">6</xref>). In contrast, cocrystallizing 300&#x02009;&#x003bc;M <italic>Ec</italic>ThrRS_G463S protein with 600&#x02009;&#x003bc;M OB did not result in an <italic>Ec</italic>ThrRS_G463S&#x02013;OB complex structure. No electron density of OB was observed in the catalytic pocket of <italic>Ec</italic>ThrRS_G463S under this condition (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2d</xref>). The active pocket of this structure has neither an OB nor substrate molecules, so it is in an &#x0201c;apo state&#x0201d;. The conformation in this state is similar to the &#x0201c;adenylation state&#x0201d; of the <italic>Ec</italic>ThrRS_Y462F&#x02013;ATP complex structure we determined earlier<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, but slightly wider (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">7</xref>). This structure also indicates that although G463S weakens ThrRS binding to OB, it does not disrupt the active conformation of ThrRS.</p><p id="Par12">To further confirm that this glycine is the key residue involved in OB sensitivity, we studied the corresponding reverse mutation (S464G) of the OB resistance gene ObaO. Similarly, we utilized a thermal shift assay and an ATP hydrolysis assay to test whether ObaO_S464G lost resistance to OB. The TSA results showed that OB increased the Tm of ObaO_WT by 3.2&#x02009;&#x000b0;C but increased the Tm of ObaO_S464G by 14.1&#x02009;&#x000b0;C (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">8a</xref>), suggesting that the S464G mutation can bind to OB. Consistently, the ATP hydrolysis assay showed that OB had no inhibitory effect on ObaO_WT but inhibited the activity of ObaO_S464G, with an IC<sub>50</sub> value of 3.9&#x02009;&#x003bc;M (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">8b</xref>). Therefore, mutation of the corresponding serine to glycine restores the sensitivity of ObaO to OB.</p><p id="Par13">Together, these results indicate that Gly463 is a key residue in ThrRS susceptibility to OB and that replacing it with a serine will induce OB resistance in ThrRS.</p></sec><sec id="Sec5"><title>The OB resistance of ThrRS mutant is not because of spatial repulsion</title><p id="Par14">In the <italic>Ec</italic>ThrRS_G463S structure, the hydroxyl group of Ser463 is 5.0&#x02009;&#x000c5; away from the phenolic hydroxyl group of Tyr462 (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>), which attacks the lactone structure of OB and forms a covalent bond with it<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Thus, the sidechain of Ser463 is too short to clash with the presumably bound OB and it is also unlikely that Ser463 will directly affect the nucleophilicity of Tyr462 and prevent it from forming a covalent bond with OB.<fig id="Fig3"><label>Fig. 3</label><caption><title>Spatial interaction between Ser463 and Gln484 does not confer OB resistance.</title><p><bold>a</bold> Zoomed-in view of the catalytic center of <italic>Ec</italic>ThrRS_G463S. Tyr462 is shown as green sticks, Ser463 is shown as slate sticks, and Gln484, Cys334, His385 and His511 are shown as pink sticks. <bold>b</bold> Superimposition of the structures of <italic>Ec</italic>ThrRS_G463S (pink cartoons) and <italic>Ec</italic>ThrRS_WT&#x02013;OB (cyan cartoons). OB is shown as transparent orange sticks. <bold>c</bold> Diagram of the Tm values of <italic>Ec</italic>ThrRS_WT and <italic>Ec</italic>ThrRS_G463S_Q484A in the presence or absence of OB and 36j. Error bars represent the standard deviations (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;4, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). All the data points are shown as small circles. <bold>d</bold> Zoomed-in view of the catalytic pocket of <italic>Ec</italic>ThrRS_G463S_Q484A which was crystallized in the presence of OB. The 2Fo-Fc electron map (blue meshes contoured at 0.8 &#x003c3;) is shown together with the structure model. Tyr462 is shown as green sticks. Ser463 and Ala484 are shown as cyan sticks. The OB binding site is circled with black dashed lines. In this state, the OB cannot form a covalent bond with Tyr462; hence, no density for OB can be seen.</p></caption><graphic xlink:href="42003_2024_6559_Fig3_HTML" id="d33e829"/></fig></p><p id="Par15">We then considered that Ser463 might have indirect effects through other OB-binding residues. In the apo state <italic>Ec</italic>ThrRS_G463S structure, the sidechain of the highly conserved residue Gln484 in the catalytic pocket forms a hydrogen bond with Tyr462, while in the OB-bound structure of the wild type (open state), the conformation of Gln484 is changed to accommodate OB (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). The distance between Ser463 and the conformation-altered Gln484 is only 1.6&#x02009;&#x000c5; (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). Therefore, if OB could induce a conformational change in Gln484 of <italic>Ec</italic>ThrRS_G463S, there might be repulsion between the two residues. To test the possibility that Ser463 might become resistant to OB by blocking the conformational change of Gln484, we designed a G463S_Q484A mutant to remove the sidechain of Gln484 to avoid potential spatial conflicts. We expected that the G463S_Q484A mutant would recover sensitivity to OB. However, in the TSA experiment, OB increased the Tm of <italic>Ec</italic>ThrRS_G463S_Q484A by 17.2&#x02009;&#x000b0;C, 10&#x02009;&#x000b0;C less than the effect of 36j (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>), suggesting that the <italic>Ec</italic>ThrRS_G463S_Q484A mutant, similar to <italic>Ec</italic>ThrRS_G463S, could still not be covalently inhibited by OB. Consistently, cocrystallizing 300&#x02009;&#x003bc;M <italic>Ec</italic>ThrRS_G463S_Q484A protein with 600&#x02009;&#x003bc;M OB did not yield an <italic>Ec</italic>ThrRS_G463S_Q484A&#x02013;OB complex structure (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">3</xref>). The <italic>Ec</italic>ThrRS_G463S_Q484A structure is still in an apo state.</p><p id="Par16">Therefore, G463S endows ThrRS with resistance to OB neither by altering the protein&#x02019;s structure nor by direct or indirect spatial repulsion.</p></sec><sec id="Sec6"><title>The glycine substitution restricts the conformational change of the active pocket of ThrRS</title><p id="Par17">In the catalytic cycle of an enzyme, the conformation of its active pocket normally exhibits a series of dynamic states. At the same time, we observed that the OB binding conformation of ThrRS is distinctly different from the apo or adenylation conformation<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Since glycine is the only nonchiral residue with the greatest flexibility, we further proposed that the G463S mutation might induce resistance to OB by altering the molecular dynamics (MD) of the protein. To investigate the role of Gly463 in the movement of the enzyme, we performed all-atom MD simulations of <italic>Ec</italic>ThrRS_WT and the <italic>Ec</italic>ThrRS_G463S mutant. Arg363 and Ala460 are two residues located on opposite sides of the OB binding pocket of ThrRS. The distance between their centroids (denoted as <italic>D</italic><sub><italic>R-A</italic></sub>) can be used to characterize changes in the size of the pocket (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a</xref>). In the MD simulation, the WT protein had two peaks in the frequency distribution curve, one corresponding to a <italic>D</italic><sub><italic>R-A</italic></sub> of 13&#x02009;&#x000c5; and the other corresponding to a <italic>D</italic><sub><italic>R-A</italic></sub> of 17&#x02009;&#x000c5; (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). In contrast, the <italic>Ec</italic>ThrRS_G463S mutant had only one peak at a <italic>D</italic><sub><italic>R-A</italic></sub> of 14&#x02009;&#x000c5; (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4b</xref>). For reference, the <italic>D</italic><sub><italic>R-A</italic></sub> is 17&#x02009;&#x000c5; when ThrRS binds OB and 12&#x02009;&#x000c5; when it binds ATP (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">9</xref>). This result suggests that the pocket of the WT protein has greater conformational variability and that the G463S replacement compresses its conformational distribution.<fig id="Fig4"><label>Fig. 4</label><caption><title>The G463S mutation altered the dynamic properties of the active pocket.</title><p><bold>a</bold> Arg363 and Ala460 are located on both sides of the inlet of the catalytic pocket where OB binds. These two residues are shown as magenta sticks. <bold>b</bold> The G463S mutation alters the distribution of the conformational states of the protein <italic>Ec</italic>ThrRS. The distance between the centers of mass of the residues Arg363 and Ala460 is defined as the width of the catalytic pocket. The conformational space shifts of WT and G463S are shown as cyan and pink curves, respectively. Eight sets of simulations with different random initial velocities were performed and data were collected from 9 to 23&#x02009;&#x000c5; per angstrom (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;8, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). <bold>c</bold>, <bold>d</bold> Dynamic cross-correlation maps (DCCM) of <italic>Ec</italic>ThrRS_WT. The dynamic cross-correlation matrix of C&#x003b1; atoms around their mean positions is calculated. The extent of correlated motions and anticorrelated motions are color-coded from blue to red, which represents positive and negative correlations, respectively. (<bold>d</bold>) is a magnified view of the region in the red box in (<bold>c</bold>). <bold>e</bold>, <bold>f</bold> DCCM of <italic>Ec</italic>ThrRS_G463S. (<bold>f</bold>) is a magnified view of the region in the red box in (<bold>e</bold>).</p></caption><graphic xlink:href="42003_2024_6559_Fig4_HTML" id="d33e987"/></fig></p><p id="Par18">The dynamic characteristics of the pocket were also visualized using dynamic cross-correlation maps (DCCM)<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>, a method that quantifies the correlation of movements between pairs of residues within a protein over the course of MD simulations. Specifically, positive correlation values observed in DCCM indicate synchronized movements between residue pairs, moving in the same direction<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, which usually reflects a structurally rigid interaction or coordination within the protein structure. Conversely, negative correlation values signify that the movements of residue pairs are opposite to each other, a phenomenon that often contributes to structural flexibility and dynamic interactions within the protein.</p><p id="Par19">The N-terminal region of <italic>Ec</italic>ThrRS (residues 1&#x02013;225) contains two domains involved in the proofreading of aminoacyl-tRNA (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">10</xref>). The constraints between this region and the catalytic domain (residues 242&#x02013;535) or the anticodon-binding domain (residues 535&#x02013;642) are weak. Therefore, the N-terminal region of <italic>Ec</italic>ThrRS was not included in our MD simulations. Residues 358&#x02013;373 and residues 432&#x02013;465 are from two opposite sides of the pocket (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">11</xref>). The motion of these two groups was negatively correlated in the MD trajectories of the WT protein, suggesting that the pocket of the WT protein is more dynamic (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4c, d</xref>). However, the motion of these two groups was positively correlated in the MD trajectories of the <italic>Ec</italic>ThrRS_G463S mutant, suggesting that the pocket of this mutant is relatively rigid (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4e, f</xref>).</p><p id="Par20">These results suggest that the conformation of the active pocket of the WT protein is more flexible and can switch to a probable conformation to expose a larger binding pocket for the binding of OB, while the G463S mutation alters the conformational variability of the binding pocket of the protein and prevents the binding event (Supplementary Movie&#x000a0;<xref rid="MOESM5" ref-type="media">1</xref>).</p></sec><sec id="Sec7"><title>A small chiral residue substitution reproduces conformation limitation and OB resistance of ThrRS</title><p id="Par21">Based on the above study, we speculated that G463S made ThrRS OB resistant due to the loss of the flexibility of the glycine residue, rather than due to the property of the serine hydroxyl sidechain. To test this speculation, we constructed an <italic>Ec</italic>ThrRS_G463A mutant. The TSA experiments showed that OB increased the Tm of <italic>Ec</italic>ThrRS_G463A by 19.5&#x02009;&#x000b0;C, which was 14.0&#x02009;&#x000b0;C less than that of the WT and 1.3&#x02009;&#x000b0;C less than the Tm of <italic>Ec</italic>ThrRS_G463A increased by 36j (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5a</xref>). In addition, ATP hydrolysis experiments showed that OB had no inhibitory effect on <italic>Ec</italic>ThrRS_G463A (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">12</xref>), indicating that <italic>Ec</italic>ThrRS_G463A is also resistant to OB.<fig id="Fig5"><label>Fig. 5</label><caption><title>The G463A mutation generates similar effects on the conformational change of ThrRS and blockage on the covalent binding of OB which were observed in the mutant G463S.</title><p><bold>a</bold> Diagram of the &#x00394;<italic>T</italic><sub>m</sub> values of <italic>Ec</italic>ThrRS_WT and <italic>Ec</italic>ThrRS_G463A in the presence or absence of OB and 36j. Error bars represent the standard deviations (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;4, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). All the data points are shown as small circles. <bold>b</bold>&#x02013;<bold>d</bold> Free energy contour maps derived from the radius of gyration (Rg) and RMSD values, where the dark blue area indicates a lower energetic conformation state. The Rg was calculated for residues 419&#x02013;467. <italic>Ec</italic>ThrRS_WT exhibited a different free energy landscape (FEL) from those of both G463S and G463A, especially possessing a larger conformational tether of Rg. <bold>e</bold> Superimposition of the structure of residues 419-467 of <italic>Ec</italic>ThrRS_WT (cyan cartoons), G463S (slate cartoons) and G463A (red cartoons) at the FEL nadir corresponding to Fig.&#x000a0;5b&#x02013;d. Residues at positions 462 and 463 are shown as sticks and circled with black dashed lines. <bold>f</bold> Superimposition of the structures of <italic>Ec</italic>ThrRS_G463A (red cartoons) and <italic>Ec</italic>ThrRS_G463S (slate cartoons). The RMSD is 0.343&#x02009;&#x000c5; over 318 C<sub>&#x003b1;</sub> atoms.</p></caption><graphic xlink:href="42003_2024_6559_Fig5_HTML" id="d33e1107"/></fig></p><p id="Par22">We also analyzed the conformational motion of <italic>Ec</italic>ThrRS_G463A by MD simulation and used <italic>D</italic><sub><italic>R-A</italic></sub> to represent the size of the pocket. The frequency curve of <italic>Ec</italic>ThrRS_G463A had only one peak at a <italic>D</italic><sub><italic>R-A</italic></sub> of approximately 14&#x02009;&#x000c5;, which was close to and slightly larger than that of <italic>Ec</italic>ThrRS_G463S (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">13</xref>). This finding suggests that the pocket of <italic>Ec</italic>ThrRS_G463A cannot be extended so that its <italic>D</italic><sub><italic>R-A</italic></sub> reaches 17&#x02009;&#x000c5; and can be effectively suppressed by OB.</p><p id="Par23">To further decipher the difference in conformational space between WT and mutant ThrRSs, we performed free energy landscape (FEL) analysis and obtained representative structures with the most stable conformations from the simulation ensembles. <italic>Ec</italic>ThrRS_WT shows a different profile of FEL from either G463S or G463A. Compared to the free energy landscapes of <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_G463A, the energy basin of <italic>Ec</italic>ThrRS_WT covers a much larger range of radii of gyration (Rg), indicating that these conformations obtained along the trajectory experienced larger conformational changes (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b-d</xref>). By comparing the conformation of residues 419-467 in the FEL nadir structure of the three proteins, we found that <italic>Ec</italic>ThrRS_WT had the most extended conformation, followed by G463A, and the narrowest was G463S (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5e</xref>). Furthermore, by comparing the FEL nadir conformation in the computational simulation and the real crystal structures, we found that the FEL nadir conformation of <italic>Ec</italic>ThrRS_WT was closer to the open state crystal structure, while the FEL nadir conformations of <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_G463A were more similar to the apo state crystal structures (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">14</xref>). These analyses suggest that the G463S and G463A mutations affect the conformational space of the ThrRS structure and cannot expose the active site for OB entry and reaction with Tyr462.</p><p id="Par24">Similarly, we cocrystallized 300&#x02009;&#x003bc;M <italic>Ec</italic>ThrRS_G463A with 600&#x02009;&#x003bc;M OB and determined a 3.0&#x02009;&#x000c5; structure (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">4</xref>). As we predicted, the Tyr462 residue was not covalently modified by OB (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">15a</xref>) and the conformation of this structure was the same as that of <italic>Ec</italic>ThrRS_G463S (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5f</xref>). Most interestingly, there are some large but discontinuous electron densities near the ATP binding site as well as the zinc ion in this structure (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">15a</xref>). These electron densities can barely accommodate the OB structure (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">15b</xref>). We suspected that this is caused by unstable binding of OB in the ThrRS active pocket. In this case, one of the phenol hydroxyl groups forms a coordination bond with the zinc ion (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6b</xref>), and the nitrophenyl group inserts into the ATP binding site between Phe379 and Arg520 (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6c</xref>). This may be an intermediate state of OB binding in ThrRS. The conformation of the wild-type ThrRS can be further opened and the nitrobenzene portion of OB can instead bind to the tRNA binding site between Tyr313 and Arg363, thus bringing the lactone ring close to Tyr462 and reacting with it to form a new covalent bond (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6d</xref>, and Supplementary Movie&#x000a0;<xref rid="MOESM6" ref-type="media">2</xref>). In contrast, the conformation of <italic>Ec</italic>ThrRS_G463A cannot be further opened, and in this binding mode, OB can be competed out by ATP (Supplementary Movie&#x000a0;<xref rid="MOESM7" ref-type="media">3</xref>). Consistent with this assumption, when <italic>Ec</italic>ThrRS_G463A was cocrystallized in the presence of both OB and ATP, only ATP was resolved in the pocket (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">16</xref>, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">5</xref>). In summary, these results suggest that Gly463, which exploits the flexibility of a glycine residue, is a key site in determining the molecular dynamics of ThrRS.<fig id="Fig6"><label>Fig. 6</label><caption><title>OB noncovalently binds to <italic>Ec</italic>ThrRS_G463A without inducing a conformational change.</title><p><bold>a</bold>, <bold>b</bold> Zoomed-in view of the catalytic pocket of <italic>Ec</italic>ThrRS_G463A, which was crystallized in the presence of OB. The 2Fo-Fc electron densities of OB, Cys334, His385, His511, Tyr462 and Ala463 (contoured at 1.0 &#x003c3;) are shown as transparent surfaces. OB does not form an ester bond with Tyr462. <bold>c</bold> Superimposition of the <italic>Ec</italic>ThrRS_Y462F&#x02013;ATP structure (yellow cartoons, PDB code: 8H99) with the <italic>Ec</italic>ThrRS_G463A&#x02013;OB structure (red cartoons). The nitrophenyl group of OB (in gray) binds between Phe379 and Arg520 where the adenine group of ATP (in purple blue) stacks. The orange parts in the middle of the panel are both terminal phosphate moieties of the cocrystallized ATP. <bold>d</bold> Superimposition of the <italic>Ec</italic>ThrRS_WT&#x02013;OB structure (marine cartoons, PDB code: 8H98) with <italic>Ec</italic>ThrRS_G463A&#x02013;OB (red cartoons). The ring-opened OB is shown as cyan sticks. The ring-closed OB is shown as gray sticks.</p></caption><graphic xlink:href="42003_2024_6559_Fig6_HTML" id="d33e1275"/></fig></p></sec><sec id="Sec8"><title>Conformation-constrained mutations cause resistance to conformation selective inhibitors</title><p id="Par25">In addition to OB, another inhibitor molecule, borrelidin (BN, Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7a</xref>), binds to ThrRS in an open conformation<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>. BN is an 18-member macrolide produced by <italic>Streptomyces rochei</italic> or <italic>Streptomyces parvulus</italic>. It binds ThrRS at a joint region of amino acid, ATP and tRNA pockets<sup><xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR41">41</xref></sup>. The BN binding conformation is very similar to the OB binding conformation (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7b</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><title>Gly463 mutations also confer resistance of <italic>Ec</italic>ThrRS to BN.</title><p><bold>a</bold> Chemical structure of borrelidin (BN). <bold>b</bold> Superimposition of the structures of <italic>Ec</italic>ThrRS_WT&#x02013;OB (PDB code: 8H98, marine cartoons) with <italic>Ec</italic>ThrRS_WT&#x02013;BN (PDB code: 4P3P, gray cartoons). The RMSD is 0.396&#x02009;&#x000c5; over 345 C&#x003b1; atoms. <bold>c</bold> Diagram of the &#x00394;Tm values of <italic>Ec</italic>ThrRS_WT/G463S/G463A in the presence or absence of BN. Error bars represent the standard deviations (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;4, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). All the data points are shown as small circles. <bold>d</bold> Inhibitory curves of BN on the ATP hydrolysis activity of <italic>Ec</italic>ThrRS_WT, G463S or G463A. Error bars represent the standard deviations (<italic>n</italic>&#x02009;&#x02009;=&#x02009;&#x02009;4, mean value&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;SD). All the data points for <italic>Ec</italic>ThrRS_WT/G463S/G463A are shown as pale blue dots, pale pink square dots, and pale red triangle dots.</p></caption><graphic xlink:href="42003_2024_6559_Fig7_HTML" id="d33e1349"/></fig></p><p id="Par26">We have shown that the pocket conformation of the G463S and G463A mutants in the lowest energy state is too small for OB to stably bind. By the same principle, they may also have some resistance to BN. We confirmed this hypothesis by TSA and ATP hydrolysis experiments. BN increased the Tm of <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_G463A by 17.4&#x02009;&#x000b0;C and 19.1&#x02009;&#x000b0;C, respectively, which were 16.5&#x02009;&#x000b0;C and 14.8&#x02009;&#x000b0;C lower than that of <italic>Ec</italic>ThrRS_WT (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7c</xref>). Similarly, BN had a strong inhibitory effect on <italic>Ec</italic>ThrRS_WT, with an IC<sub>50</sub> value of 559&#x02009;nM in the presence of 2&#x02009;&#x003bc;M ATP and 20 &#x003bc;M <sc>l</sc>-Thr, but the inhibitory effect of both <italic>Ec</italic>ThrRS_G463S and <italic>Ec</italic>ThrRS_G463A decreased by more than 20-fold (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7d</xref>). These results suggest that conformation-constrained mutations also render ThrRS resistant to other conformation-selective inhibitors, such as BN.</p></sec></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p id="Par27">In summary, by studying the resistance of ObaO to OB, we found that a key glycine residue (Gly463) of ThrRS plays a dominant role in the molecular dynamics of the protein. Its substitution by small chiral amino acid residues significantly constrains the conformational space of ThrRS; therefore, we propose a general mechanism of ThrRS resistance to conformation-selective inhibitors, including OB and BN.</p><p id="Par28">Gly463 is a highly conserved residue in the housekeeping ThrRSs. It is possible that the OB-resistant G463S substitution compromises enzyme activity. To our surprise, we found that the ATP hydrolysis activity of the Gly463 mutants was higher than that of the wild type (Supplementary Fig.&#x000a0;<xref rid="MOESM2" ref-type="media">17</xref>). The mutation does not appear to have an adverse effect on the activity of the enzyme catalyzed amino acid activation. On the other hand, we noticed that the recombinant expression of Gly463 mutants produced more inclusion bodies than that of the wild type. Consistent with the discovery that Gly463 is critical to protein conformation, mutations in this residue may also sacrifice some of the cost of protein folding.</p><p id="Par29">Functional proteins are in constant motion<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Structural flexibility allows proteins to adapt to their individual molecular binding partners and facilitates the binding process<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. For example, the dynamics of bacterial leucyl-tRNA synthetase (LeuRS) allow for the whole catalytic cycle, while single mutations that affect global dynamics can reduce the catalytic efficiency of the enzyme<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. Moreover, information such as the location and dynamic properties of drug binding pockets on proteins is critical for structure-based drug design and optimization of lead compounds<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>.</p><p id="Par30">Considering the dynamics of protein pockets during drug development may increase the accuracy of pocket identification and reveal alternative shapes or even a new transient pocket<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>. For example, a recent retrospective structure-based virtual screen (SBVS) study showed that the exploration of binding pocket dynamics in SBVS of sirtuin 2 inhibitors could achieve significant improvements in screening performance<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>; a combination of experimental and computational methods of pocket dynamics successfully discovered an inhibitor that discriminates <italic>Plasmodium falciparum</italic> heat shock protein 90 from its human homolog<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>.</p><p id="Par31">Although not widely studied, MD is also thought to give insight into the reasons for potential resistance development. For example, a combination of bioinformatics analysis and MD simulations showed that the L528W mutation of Bruton&#x02019;s Tyrosine Kinase (BTK) reduces the conformational stability of BTK and decreased its binding affinity to ibrutinib compared to that of the WT, leading to drug resistance and potential disease recurrence<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>.</p><p id="Par32">In recent years, the development of drugs targeting aaRSs has received increasing amounts of attention. Our research suggested that molecular dynamics is an important factor in the design of drugs targeting aaRSs. This work not only elucidates the molecular mechanism of the self-resistance of OB-producing <italic>P. fluorescens</italic> that is equipped with a serine substitution at residue 464 (corresponding to Gly463 in <italic>Ec</italic>ThrRS) in the ObaO protein, but also emphasizes the importance of backbone kinetics, which is often hidden in static crystal structures, for aaRS-targeting drug development.</p></sec><sec id="Sec10"><title>Methods</title><sec id="Sec11"><title>Protein purification</title><p id="Par33">The <italic>E. coli</italic> ThrRS (residues 242-642, Supplementary Note&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref>) wild type, G463S, L489M, G463S_Q484A, G463A, A316N mutants, and the <italic>P. fluorescens</italic> ObaO (residues 241-637) and S464G mutant were constructed in a pET28a vector attended with a 6&#x000d7;His-tag at the <italic>C</italic>-terminus. Each protein was expressed in the BL21 (<italic>DE3</italic>) strain and induced with 0.5&#x02009;mM isopropyl-<italic>&#x003b2;</italic>-D-thiogalactoside for 20&#x02009;h at 16&#x02009;&#x000b0;C. The cell pellet (from 2 L) was lysed in buffer A (25&#x02009;mM Tris pH 7.5, 500&#x02009;mM NaCl, and 25&#x02009;mM imidazole), loaded onto a Ni-Hitrap column (Cytiva, USA), washed with buffer A, and then eluted with a gradient increasing percentage of buffer B (25&#x02009;mM Tris pH 7.5, 500&#x02009;mM NaCl, and 250&#x02009;mM imidazole) by a &#x004d2;KTA pure&#x02122; system (Cytiva, USA). The eluted protein was further purified by a Hitrap Q HP anion exchange column (Cytiva, USA) with gradient NaCl buffer (0.05&#x02013;1&#x02009;M NaCl in 25&#x02009;mM Tris pH 7.5).</p></sec><sec id="Sec12"><title>Crystallization</title><p id="Par34">For crystallization, the protein was further purified by a gel filtration S200 Increase column (Cytiva, USA) with a buffer containing 25&#x02009;mM Tris pH 7.5, 200&#x02009;mM NaCl, and 1&#x02009;mM MgCl<sub>2</sub>. All crystallization experiments were performed at 18&#x02009;&#x000b0;C based on the sitting-drop method<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. All proteins were concentrated to 15&#x02009;mg/mL using a 10&#x02009;kDa centrifugal filter (Millipore, USA). Before crystallization, OB (GlpBio, US) was mixed with protein at twice the molar ratio on ice for 1&#x02009;h. ATP was mixed with protein at a fivefold molar ratio on ice for 1&#x02009;h if added. For the microbatch crystallization screen, 0.5&#x02009;&#x003bc;L of protein solution was mixed with an equal amount of precipitant solution (Molecular dimensions, UK) in microbatch 96-well plates using a Gryphon robot (ART technology, USA). Crystals grew to their final dimensions within 1&#x02013;3 days.</p><p id="Par35">The <italic>Ec</italic>ThrRS_G463S crystals were obtained from the condition of 0.02&#x02009;M sodium formate, 0.02&#x02009;M ammonium acetate, 0.02&#x02009;M sodium citrate tribasic, 0.02&#x02009;M potassium sodium tartrate tetrahydrate, 0.02&#x02009;M sodium oxamate, 0.045&#x02009;M imidazole, 0.055&#x02009;M MES monohydrate pH 6.5, 20% v/v PEG 500&#x02009;MME, and 10% w/v PEG 20000.</p><p id="Par36">The <italic>Ec</italic>ThrRS_L489M&#x02013;OB crystals were obtained from the condition of 2.0 M ammonium sulfate, and 0.15&#x02009;M sodium citrate pH 5.5. 0.02&#x02009;M DL-glutamic acid monohydrate, 0.02&#x02009;M DL-alanine, 0.02&#x02009;M glycine, 0.02&#x02009;M DL-lysine monohydrochloride, 0.02&#x02009;M DL-serine, 0.061&#x02009;M Tris, 0.039&#x02009;M bicine pH 8.5, 12.5% v/v MPD, 12.5% w/v PEG 1000, and 12.5% w/v PEG 3350.</p><p id="Par37">The <italic>Ec</italic>ThrRS_G463S_Q484A crystals were obtained from the condition of 0.03&#x02009;M magnesium chloride hexahydrate, 0.03&#x02009;M calcium chloride dihydrate, 0.05&#x02009;M sodium HEPES, 0.05&#x02009;M MOPS pH 7.5, 20% v/v PEG 500 MME, and 10% w/v PEG 20000.</p><p id="Par38">The <italic>Ec</italic>ThrRS_G463A&#x02013;OB crystals were obtained from the condition of 0.02&#x02009;M D-glucose, 0.02&#x02009;M D-mannose, 0.02&#x02009;M D-galactose, 0.02 M L-fucose, 0.02&#x02009;M D-xylose, 0.02 M <italic>N</italic>-acetyl-D-glucosamine, 0.05&#x02009;M sodium HEPES, 0.05&#x02009;M MOPS pH 7.5, 12.5% v/v MPD, 12.5% w/v PEG 1000, and 12.5% w/v PEG 3350.</p><p id="Par39">The <italic>Ec</italic>ThrRS_G463A&#x02013;OB crystals were obtained from the condition of 0.03&#x02009;M diethylene glycol, 0.03&#x02009;M triethylene glycol, 0.03&#x02009;M tetraethylene glycol, 0.03&#x02009;M pentaethylene glycol, 0.05&#x02009;M sodium HEPES, 0.05&#x02009;M MOPS pH 7.5, 20% v/v ethylene glycol, and 10% w/v PEG 8000.</p><p id="Par40">The <italic>Ec</italic>ThrRS_G463A&#x02013;ATP crystals were obtained from the condition of 0.03&#x02009;M magnesium chloride hexahydrate, 0.03&#x02009;M calcium chloride dihydrate, 0.045&#x02009;M imidazole, 0.055&#x02009;M MES monohydrate pH 6.5, 20% v/v glycerol, and 10% w/v PEG 4000.</p></sec><sec id="Sec13"><title>Data collection and structure determination</title><p id="Par41">The resulting crystals were flash-frozen in liquid nitrogen for data collection. The data were obtained from beamlines 10U2 or 02U1 at the Shanghai Synchrotron Radiation Facility (SSRF). Then, the datasets were indexed and integrated with XDS<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> or automatically processed by AutoPROC<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> at the Shanghai Synchrotron Radiation Facility (SSRF). The HKL files were scaled and merged with Aimless in the CCP4 suite<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. The structures were determined by molecular replacement using the <italic>Ec</italic>ThrRS&#x02013;OB structure (PDB: 8H98) or the <italic>Ec</italic>ThrRS structure (PDB: 1EVK) as a searching model in the Phaser program in the CCP4 suite<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. After corrections for the bulk solvent and overall B values, the data were refined by iterative cycles of positional refinement and TLS refinement with PHENIX<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> and model building with COOT<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. All current models had good geometry and no residues were in the disallowed region of the Ramachandran plot. The data collection and model statistics are given in Supplementary Tables&#x000a0;<xref rid="MOESM2" ref-type="media">1</xref>&#x02013;<xref rid="MOESM2" ref-type="media">5</xref>.</p></sec><sec id="Sec14"><title>Thermal shift assay</title><p id="Par42">The <italic>Ec</italic>ThrRS_WT and L489M/G463S/G463S_Q484A/G463A/A316N mutant proteins, ObaO_WT and ObaO_S464G mutant proteins were prepared at 2&#x02009;&#x003bc;M in buffer containing 25&#x02009;mM Tris-HCl pH 7.5, 200&#x02009;mM NaCl, and 20&#x02009;&#x003bc;M OB (GlpBio, US) or BN (GlpBio, US) or ddH<sub>2</sub>O in equal volumes since the compounds were diluted with ddH<sub>2</sub>O to 1&#x02009;mM as stocks. Compound 36j was assayed at the same final concentration as a positive control. SYPRO orange dye (Sigma, USA) was diluted in assay buffer containing 25&#x02009;mM Tris-HCl pH 7.5 and 200&#x02009;mM NaCl to a 40&#x000d7; concentration, and was added to the mixture to a final 4&#x000d7; concentration. Aliquots (20&#x02009;&#x003bc;L) were added to a 96-well PCR plate. After complete mixing, the final solutions were heated from 25 to 95&#x02009;&#x000b0;C at a rate of 0.015&#x02009;&#x000b0;C/s, and fluorescence signals were monitored by QuantStudio 3 (Applied Biosystems by Thermo Fisher Scientific, USA). The melting temperature (Tm) was calculated through a previously established method<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>.</p></sec><sec id="Sec15"><title>ATP hydrolysis assay</title><p id="Par43">200&#x02009;nM <italic>Ec</italic>ThrRS wide type and mutants, ObaO and ObaO_S464G mutant were incubated with serially diluted OB (0 to 10&#x02009;&#x003bc;M for <italic>Ec</italic>ThrRS, 0 to 40&#x02009;&#x003bc;M for ObaO) in a buffer containing 25&#x02009;mM HEPES pH 7.5, 50&#x02009;mM NaCl, 40&#x02009;mM MgCl<sub>2</sub>, 30&#x02009;mM KCl, 0.01&#x02009;mg/mL bovine serum albumin (BSA), and 0.004% Tween-20 at 37&#x02009;&#x000b0;C for 4&#x02009;h and then mixed 1:1 with a substrate mixture containing 4&#x02009;&#x003bc;M ATP, 40 &#x003bc;M <sc>l</sc>-threonine, 25&#x02009;mM HEPES pH 7.5, 50&#x02009;mM NaCl, 40&#x02009;mM MgCl<sub>2</sub>, 30&#x02009;mM KCl, 0.01&#x02009;mg/mL BSA, and 0.004% Tween-20. The ATP hydrolysis reaction was performed at 37&#x02009;&#x000b0;C for 4&#x02009;h.</p><p id="Par44">To evaluate the relative ATP hydrolysis rate of <italic>Ec</italic>ThrRS_WT, Y462F, G463S and G463A, a reaction mixture containing 200&#x02009;nM <italic>Ec</italic>ThrRS, 2&#x02009;&#x003bc;M ATP, 20 &#x003bc;M <sc>l</sc>-threonine, 25&#x02009;mM HEPES pH 7.5, 50&#x02009;mM NaCl, 40&#x02009;mM MgCl<sub>2</sub>, 30&#x02009;mM KCl, 0.01&#x02009;mg/mL BSA, and 0.004% Tween-20 was incubated at 37&#x02009;&#x000b0;C for 4&#x02009;h.</p><p id="Par45">After incubation, the detection solution from the Kinase-Glo<sup>&#x000ae;</sup> luminescent kit (Promega, USA) was added to the reaction system at a 1:1 ratio, and the mixture was gently shaken for 10&#x02009;min. The chemiluminescence signal was measured using a microplate reader (Tecan, USA). All experiments were performed in four replicates. The data were processed using GraphPad Prism 8 software.</p></sec><sec id="Sec16"><title>Molecular dynamics (MD) simulations</title><p id="Par46">MD simulations were performed by using the Desmond<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> package of Schr&#x000f6;dinger2023-1 with the OPLS4 force field<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. The initial conformation of <italic>Ec</italic>ThrRS_G463S was obtained from the crystal structure determined in this work. To maintain consistency in the MD starting point and explore the inherent conformational space, the initial conformations of <italic>Ec</italic>ThrRS_WT and <italic>Ec</italic>ThrRS_G463A were obtained from a single mutation of the <italic>Ec</italic>ThrRS_G463S crystal structure. All systems were explicitly solvated with TIP3P water molecules<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> under cubic periodic boundary conditions for a 15&#x02009;&#x000c5; buffer region. The overlapping water molecules were removed, 0.15&#x02009;M KCl was added, and the system was neutralized by adding K<sup>+</sup> as a counter ion. Brownian motion simulation was used to relax these systems into local energy minimum states separately. An ensemble (NPT) was then applied to maintain a constant temperature (310&#x02009;K) and pressure (1.01325&#x02009;bar) of the systems. For <italic>Ec</italic>ThrRS_WT and the two introduced mutants, 8 sets of simulations with different random initial velocities were started at 310&#x02009;K, with each set lasting 400&#x02009;ns. The simulations described above were performed using the AutoMD<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://github.com/Wang-Lin-boop/AutoMD">https://github.com/Wang-Lin-boop/AutoMD</ext-link>) script to handle the system and control the simulation process. To avoid artifacts caused by periodicity, we processed the trajectory using <italic>trj_center.py</italic>. The distance between residue pairs was monitored by using <italic>trajectory_asl_monitor.py</italic>. The root mean square deviation (RMSD) and radius of gyration (Rg) were calculated by using <italic>analyze_simulation.py</italic>. Gromacs sham<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> and Matplotlib were used to calculate and visualize the three-dimensional Gibbs free energy surface with RMSD and Rg. The dynamic cross-correlation matrix (DCCM) was calculated and plotted by using the script <italic>trj_essential_dynamics.py</italic>. The process and analysis of trajectories described above were performed using the AutoTRJ (<ext-link ext-link-type="uri" xlink:href="https://github.com/Wang-Lin-boop/AutoMD/blob/main/AutoTRJ">https://github.com/Wang-Lin-boop/AutoMD/blob/main/AutoTRJ</ext-link>) script. All of these simulation analysis scripts are from Schr&#x000f6;dinger, Inc. The dynamics simulation movies were visualized by using VMD.</p></sec><sec id="Sec17"><title>Statistics and reproducibility</title><p id="Par47">Enzymatic assay and thermal shift measurements were conducted in four repeats. MD simulations were conducted in eight repeats with different random initial velocities. Acquired data are presented as the mean values&#x02009;&#x02009;&#x000b1;&#x02009;&#x02009;standard deviation (SD).</p></sec><sec id="Sec18"><title>Reporting summary</title><p id="Par48">Further information on research design is available in the&#x000a0;<xref rid="MOESM8" ref-type="media">Nature Portfolio Reporting Summary</xref> linked to this article.</p></sec></sec><sec sec-type="supplementary-material"><sec id="Sec19"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="42003_2024_6559_MOESM1_ESM.pdf"><caption><p>Transparent Peer Review file</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="42003_2024_6559_MOESM2_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="42003_2024_6559_MOESM3_ESM.pdf"><caption><p>Description of Additional Supplementary Materials</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="42003_2024_6559_MOESM4_ESM.xlsx"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="42003_2024_6559_MOESM5_ESM.mp4"><caption><p>Supplementary Movie 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="42003_2024_6559_MOESM6_ESM.mp4"><caption><p>Supplementary Movie 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="42003_2024_6559_MOESM7_ESM.mp4"><caption><p>Supplementary Movie 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="42003_2024_6559_MOESM8_ESM.pdf"><caption><p>reporting summary</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Hang Qiao, Zilu Wang, Hao Yang.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s42003-024-06559-x.</p></sec><ack><title>Acknowledgements</title><p>The authors thank Prof. Huihao Zhou for his helpful discussion and generous supply of compound 36j. We gratefully acknowledge the help from the staff of beamlines 10U2 and 02U1 at the Shanghai Synchrotron Radiation Facility. This work is supported by the National Key Research and Development Program of China grant 2022YFC2303100, National Natural Science Foundation of China grants 22277132 and 22277134, Shanghai Science and Technology Committee grant 22ZR1475000, the State Key Laboratory of Chemical Biology, Guangdong Provincial Key Laboratory of Construction Foundation, 2023B1212060022, and funding support from the National Key R&#x00026;D Program of China (2022YFC3400500 and 2022YFC3400501) and the Shanghai Frontiers Science Center for Biomacromolecules and Precision Medicine at ShanghaiTech University. We also thank the HPC Platform of ShanghaiTech University.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Investigation and methodology, H.Q., Z.W., H.Y., M.X. and G.Y.; review, editing, and writing, H.Q., Z.W., H.Y., F.B., J.W., and P.F.; conceptualization and supervision, F.B., J.W., and P.F. All authors read and approved the final manuscript.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par49"><italic>Communications Biology</italic> thanks Charles W. Carter Jr and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Tuan Anh Nguyen and Christina Karlsson Rosenthal. A peer review file is available.</p></sec></notes><notes notes-type="data-availability"><title>Data availability</title><p>Atomic coordinates and structure factors for the reported crystal structures have been deposited with the Protein Data Bank under accession numbers 8WIH, 8WIG, 8WII, 8WIA, and 8WIJ. The source data behind the graphs are available as Supplementary Data&#x000a0;<xref rid="MOESM4" ref-type="media">1</xref>.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par50">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>CW</given-names><suffix>Jr</suffix></name><name><surname>Wills</surname><given-names>PR</given-names></name></person-group><article-title>The roots of genetic coding in aminoacyl-tRNA synthetase duality</article-title><source>Annu. Rev. Biochem.</source><year>2021</year><volume>90</volume><fpage>349</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1146/annurev-biochem-071620-021218</pub-id><?supplied-pmid 33781075?><pub-id pub-id-type="pmid">33781075</pub-id>
</element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio Gomez</surname><given-names>MA</given-names></name><name><surname>Ibba</surname><given-names>M</given-names></name></person-group><article-title>Aminoacyl-tRNA synthetases</article-title><source>Rna</source><year>2020</year><volume>26</volume><fpage>910</fpage><lpage>936</lpage><pub-id pub-id-type="doi">10.1261/rna.071720.119</pub-id><?supplied-pmid 32303649?><pub-id pub-id-type="pmid">32303649</pub-id>
</element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Pang, L., Weeks, S. D. &#x00026; Van Aerschot, A. Aminoacyl-tRNA synthetases as valuable targets for antimicrobial drug discovery. <italic>Int. J. Mol. Sci.</italic><bold>22</bold> (2021).</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>SC</given-names></name><name><surname>Griffin</surname><given-names>MDW</given-names></name><name><surname>Winzeler</surname><given-names>EA</given-names></name><name><surname>Ribas de Pouplana</surname><given-names>L</given-names></name><name><surname>Tilley</surname><given-names>L</given-names></name></person-group><article-title>Targeting aminoacyl tRNA synthetases for antimalarial drug development</article-title><source>Annu. Rev. Microbiol.</source><year>2023</year><volume>77</volume><fpage>111</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1146/annurev-micro-032421-121210</pub-id><?supplied-pmid 37018842?><pub-id pub-id-type="pmid">37018842</pub-id>
</element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>NH</given-names></name><name><surname>Fox</surname><given-names>PL</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name></person-group><article-title>Aminoacyl-tRNA synthetases as therapeutic targets</article-title><source>Nat. Rev. Drug Discov.</source><year>2019</year><volume>18</volume><fpage>629</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1038/s41573-019-0026-3</pub-id><?supplied-pmid 31073243?><pub-id pub-id-type="pmid">31073243</pub-id>
</element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neenan</surname><given-names>TX</given-names></name><name><surname>Burrier</surname><given-names>RE</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name></person-group><article-title>Biocon&#x02019;s target factory</article-title><source>Nat. Biotechnol.</source><year>2018</year><volume>36</volume><fpage>791</fpage><lpage>797</lpage><pub-id pub-id-type="doi">10.1038/nbt.4242</pub-id><?supplied-pmid 30188545?><pub-id pub-id-type="pmid">30188545</pub-id>
</element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>732</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-00785-0</pub-id><?supplied-pmid 28963468?><pub-id pub-id-type="pmid">28963468</pub-id>
</element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Chemical inhibition of prometastatic lysyl-tRNA synthetase-laminin receptor interaction</article-title><source>Nat. Chem. Biol.</source><year>2014</year><volume>10</volume><fpage>29</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1038/nchembio.1381</pub-id><?supplied-pmid 24212136?><pub-id pub-id-type="pmid">24212136</pub-id>
</element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>P</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name></person-group><article-title>Evolutionary limitation and opportunities for developing tRNA synthetase inhibitors with 5-binding-mode classification</article-title><source>Life</source><year>2015</year><volume>5</volume><fpage>1703</fpage><lpage>1725</lpage><pub-id pub-id-type="doi">10.3390/life5041703</pub-id><?supplied-pmid 26670257?><pub-id pub-id-type="pmid">26670257</pub-id>
</element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>XL</given-names></name><name><surname>Schimmel</surname><given-names>P</given-names></name></person-group><article-title>ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase</article-title><source>Nature</source><year>2013</year><volume>494</volume><fpage>121</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nature11774</pub-id><?supplied-pmid 23263184?><pub-id pub-id-type="pmid">23263184</pub-id>
</element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baragana</surname><given-names>B</given-names></name><etal/></person-group><article-title>Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2019</year><volume>116</volume><fpage>7015</fpage><lpage>7020</lpage><pub-id pub-id-type="doi">10.1073/pnas.1814685116</pub-id><?supplied-pmid 30894487?><pub-id pub-id-type="pmid">30894487</pub-id>
</element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>TL</given-names></name><name><surname>Yin</surname><given-names>YW</given-names></name><name><surname>Carter</surname><given-names>CW</given-names><suffix>Jr.</suffix></name></person-group><article-title>Selective inhibition of bacterial Tryptophanyl-tRNA synthetases by indolmycin is mechanism-based</article-title><source>J. Biol. Chem.</source><year>2016</year><volume>291</volume><fpage>255</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.690321</pub-id><?supplied-pmid 26555258?><pub-id pub-id-type="pmid">26555258</pub-id>
</element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group><article-title>Atomic resolution analyses of isocoumarin derivatives for inhibition of Lysyl-tRNA synthetase</article-title><source>ACS Chem. Biol.</source><year>2020</year><volume>15</volume><fpage>1016</fpage><lpage>1025</lpage><pub-id pub-id-type="doi">10.1021/acschembio.0c00032</pub-id><?supplied-pmid 32195573?><pub-id pub-id-type="pmid">32195573</pub-id>
</element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><etal/></person-group><article-title>Inhibitory mechanism of reveromycin A at the tRNA binding site of a class I synthetase</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>1616</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-21902-0</pub-id><?supplied-pmid 33712620?><pub-id pub-id-type="pmid">33712620</pub-id>
</element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rock</surname><given-names>FL</given-names></name><etal/></person-group><article-title>An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site</article-title><source>Science</source><year>2007</year><volume>316</volume><fpage>1759</fpage><lpage>1761</lpage><pub-id pub-id-type="doi">10.1126/science.1142189</pub-id><?supplied-pmid 17588934?><pub-id pub-id-type="pmid">17588934</pub-id>
</element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Ruysscher</surname><given-names>D</given-names></name><etal/></person-group><article-title>Synthesis and structure-activity studies of novel anhydrohexitol-based Leucyl-tRNA synthetase inhibitors</article-title><source>Eur. J. Medicinal Chem.</source><year>2021</year><volume>211</volume><fpage>113021</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2020.113021</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname><given-names>M</given-names></name><etal/></person-group><article-title>Identification of bacteria-selective threonyl-tRNA synthetase substrate inhibitors by structure-based design</article-title><source>J. Medicinal Chem.</source><year>2013</year><volume>56</volume><fpage>1748</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1021/jm301756m</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abibi</surname><given-names>A</given-names></name><etal/></person-group><article-title>The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability</article-title><source>J. Biol. Chem.</source><year>2014</year><volume>289</volume><fpage>21651</fpage><lpage>21662</lpage><pub-id pub-id-type="doi">10.1074/jbc.M114.574061</pub-id><?supplied-pmid 24936059?><pub-id pub-id-type="pmid">24936059</pub-id>
</element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>M</given-names></name><etal/></person-group><article-title>Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines</article-title><source>Nat. Commun.</source><year>2021</year><volume>12</volume><fpage>343</fpage><pub-id pub-id-type="doi">10.1038/s41467-020-20478-5</pub-id><?supplied-pmid 33436639?><pub-id pub-id-type="pmid">33436639</pub-id>
</element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group><article-title>Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>11566</fpage><lpage>11576</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa862</pub-id><?supplied-pmid 33053158?><pub-id pub-id-type="pmid">33053158</pub-id>
</element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Design, Synthesis, and Proof-of-Concept of Triple-Site Inhibitors against Aminoacyl-tRNA Synthetases</article-title><source>J. Medicinal Chem.</source><year>2022</year><volume>65</volume><fpage>5800</fpage><lpage>5820</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.2c00134</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vondenhoff</surname><given-names>GH</given-names></name><etal/></person-group><article-title>Extended targeting potential and improved synthesis of Microcin C analogs as antibacterials</article-title><source>Bioorg. Medicinal Chem.</source><year>2011</year><volume>19</volume><fpage>5462</fpage><lpage>5467</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2011.07.052</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>S</given-names></name><etal/></person-group><article-title>Plant tumour biocontrol agent employs a tRNA-dependent mechanism to inhibit leucyl-tRNA synthetase</article-title><source>Nat. Commun.</source><year>2013</year><volume>4</volume><fpage>1417</fpage><pub-id pub-id-type="doi">10.1038/ncomms2421</pub-id><?supplied-pmid 23361008?><pub-id pub-id-type="pmid">23361008</pub-id>
</element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><etal/></person-group><article-title>Structural characterization of free-state and product-state Mycobacterium tuberculosis methionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism</article-title><source>IUCrJ</source><year>2018</year><volume>5</volume><fpage>478</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1107/S2052252518008217</pub-id><?supplied-pmid 30002848?><pub-id pub-id-type="pmid">30002848</pub-id>
</element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy</article-title><source>Science</source><year>2022</year><volume>376</volume><fpage>1074</fpage><lpage>1079</lpage><pub-id pub-id-type="doi">10.1126/science.abn0611</pub-id><?supplied-pmid 35653481?><pub-id pub-id-type="pmid">35653481</pub-id>
</element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Immunity-guided identification of threonyl-tRNA synthetase as the molecular target of obafluorin, a beta-lactone antibiotic</article-title><source>ACS Chem. Biol.</source><year>2019</year><volume>14</volume><fpage>2663</fpage><lpage>2671</lpage><pub-id pub-id-type="doi">10.1021/acschembio.9b00590</pub-id><?supplied-pmid 31675206?><pub-id pub-id-type="pmid">31675206</pub-id>
</element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>JS</given-names></name><name><surname>Trejo</surname><given-names>WH</given-names></name><name><surname>Principe</surname><given-names>PA</given-names></name><name><surname>Sykes</surname><given-names>RB</given-names></name></person-group><article-title>Obafluorin, a novel beta-lactone produced by Pseudomonas fluorescens. Taxonomy, fermentation and biological properties</article-title><source>J. Antibiotics</source><year>1984</year><volume>37</volume><fpage>802</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.37.802</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>P</given-names></name><etal/></person-group><article-title>l-Threonine transaldolase activity is enabled by a persistent catalytic intermediate</article-title><source>ACS Chem. Biol.</source><year>2021</year><volume>16</volume><fpage>86</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1021/acschembio.0c00753</pub-id><?supplied-pmid 33337128?><pub-id pub-id-type="pmid">33337128</pub-id>
</element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaffer</surname><given-names>JE</given-names></name><name><surname>Reck</surname><given-names>MR</given-names></name><name><surname>Prasad</surname><given-names>NK</given-names></name><name><surname>Wencewicz</surname><given-names>TA</given-names></name></person-group><article-title>beta-Lactone formation during product release from a nonribosomal peptide synthetase</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>737</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2374</pub-id><?supplied-pmid 28504677?><pub-id pub-id-type="pmid">28504677</pub-id>
</element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>TA</given-names></name><name><surname>Heine</surname><given-names>D</given-names></name><name><surname>Qin</surname><given-names>Z</given-names></name><name><surname>Wilkinson</surname><given-names>B</given-names></name></person-group><article-title>An L-threonine transaldolase is required for L-threo-beta-hydroxy-alpha-amino acid assembly during obafluorin biosynthesis</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>15935</fpage><pub-id pub-id-type="doi">10.1038/ncomms15935</pub-id><?supplied-pmid 28649989?><pub-id pub-id-type="pmid">28649989</pub-id>
</element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitler</surname><given-names>DF</given-names></name><name><surname>Gemmell</surname><given-names>EM</given-names></name><name><surname>Schaffer</surname><given-names>JE</given-names></name><name><surname>Wencewicz</surname><given-names>TA</given-names></name><name><surname>Gulick</surname><given-names>AM</given-names></name></person-group><article-title>The structural basis of N-acyl-alpha-amino-beta-lactone formation catalyzed by a nonribosomal peptide synthetase</article-title><source>Nat. Commun.</source><year>2019</year><volume>10</volume><fpage>3432</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-11383-7</pub-id><?supplied-pmid 31366889?><pub-id pub-id-type="pmid">31366889</pub-id>
</element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Discovery of L-threonine transaldolases for enhanced biosynthesis of beta-hydroxylated amino acids</article-title><source>Commun. Biol.</source><year>2023</year><volume>6</volume><fpage>929</fpage><pub-id pub-id-type="doi">10.1038/s42003-023-05293-0</pub-id><?supplied-pmid 37696954?><pub-id pub-id-type="pmid">37696954</pub-id>
</element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batey</surname><given-names>SFD</given-names></name><etal/></person-group><article-title>The catechol moiety of obafluorin is essential for antibacterial activity</article-title><source>RSC Chem. Biol.</source><year>2023</year><volume>4</volume><fpage>926</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1039/D3CB00127J</pub-id><?supplied-pmid 37920400?><pub-id pub-id-type="pmid">37920400</pub-id>
</element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Tyrosine-targeted covalent inhibition of a tRNA synthetase aided by zinc ion</article-title><source>Commun. Biol.</source><year>2023</year><volume>6</volume><fpage>107</fpage><pub-id pub-id-type="doi">10.1038/s42003-023-04517-7</pub-id><?supplied-pmid 36707692?><pub-id pub-id-type="pmid">36707692</pub-id>
</element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><?supplied-pmid 34265844?><pub-id pub-id-type="pmid">34265844</pub-id>
</element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sankaranarayanan</surname><given-names>R</given-names></name><etal/></person-group><article-title>The structure of threonyl-tRNA synthetase-tRNA(Thr) complex enlightens its repressor activity and reveals an essential zinc ion in the active site</article-title><source>Cell</source><year>1999</year><volume>97</volume><fpage>371</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80746-1</pub-id><?supplied-pmid 10319817?><pub-id pub-id-type="pmid">10319817</pub-id>
</element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichiye</surname><given-names>T</given-names></name><name><surname>Karplus</surname><given-names>M</given-names></name></person-group><article-title>Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations</article-title><source>Proteins</source><year>1991</year><volume>11</volume><fpage>205</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1002/prot.340110305</pub-id><?supplied-pmid 1749773?><pub-id pub-id-type="pmid">1749773</pub-id>
</element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>GE</given-names></name><name><surname>Ornstein</surname><given-names>RL</given-names></name></person-group><article-title>Molecular dynamics study of time-correlated protein domain motions and molecular flexibility: cytochrome P450BM-3</article-title><source>Biophys. J.</source><year>1997</year><volume>73</volume><fpage>1147</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1016/S0006-3495(97)78147-5</pub-id><?supplied-pmid 9284282?><pub-id pub-id-type="pmid">9284282</pub-id>
</element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase</article-title><source>Nat. Commun.</source><year>2015</year><volume>6</volume><fpage>6402</fpage><pub-id pub-id-type="doi">10.1038/ncomms7402</pub-id><?supplied-pmid 25824639?><pub-id pub-id-type="pmid">25824639</pub-id>
</element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olano</surname><given-names>C</given-names></name><etal/></person-group><article-title>Biosynthesis of the angiogenesis inhibitor borrelidin by Streptomyces parvulus Tu4055: cluster analysis and assignment of functions</article-title><source>Chem. Biol.</source><year>2004</year><volume>11</volume><fpage>87</fpage><lpage>97</lpage><?supplied-pmid 15112998?><pub-id pub-id-type="pmid">15112998</pub-id>
</element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>CX</given-names></name><etal/></person-group><article-title>Antifungal activity of borrelidin produced by a Streptomyces strain isolated from soybean</article-title><source>J. Agric. Food Chem.</source><year>2012</year><volume>60</volume><fpage>1251</fpage><lpage>1257</lpage><pub-id pub-id-type="doi">10.1021/jf2044982</pub-id><?supplied-pmid 22242825?><pub-id pub-id-type="pmid">22242825</pub-id>
</element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>MD</given-names></name><name><surname>Phillips</surname><given-names>GN</given-names><suffix>Jr</suffix></name></person-group><article-title>Moving beyond static snapshots: Protein dynamics and the Protein Data Bank</article-title><source>J. Biol. Chem.</source><year>2021</year><volume>296</volume><fpage>100749</fpage><pub-id pub-id-type="doi">10.1016/j.jbc.2021.100749</pub-id><?supplied-pmid 33961840?><pub-id pub-id-type="pmid">33961840</pub-id>
</element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stank</surname><given-names>A</given-names></name><name><surname>Kokh</surname><given-names>DB</given-names></name><name><surname>Fuller</surname><given-names>JC</given-names></name><name><surname>Wade</surname><given-names>RC</given-names></name></person-group><article-title>Protein binding pocket dynamics</article-title><source>Acc. Chem. Res.</source><year>2016</year><volume>49</volume><fpage>809</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1021/acs.accounts.5b00516</pub-id><?supplied-pmid 27110726?><pub-id pub-id-type="pmid">27110726</pub-id>
</element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Partitioning of the initial catalytic steps of leucyl-tRNA synthetase is driven by an active site peptide-plane flip</article-title><source>Commun. Biol.</source><year>2022</year><volume>5</volume><fpage>883</fpage><pub-id pub-id-type="doi">10.1038/s42003-022-03825-8</pub-id><?supplied-pmid 36038645?><pub-id pub-id-type="pmid">36038645</pub-id>
</element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nisius</surname><given-names>B</given-names></name><name><surname>Sha</surname><given-names>F</given-names></name><name><surname>Gohlke</surname><given-names>H</given-names></name></person-group><article-title>Structure-based computational analysis of protein binding sites for function and druggability prediction</article-title><source>J. Biotechnol.</source><year>2012</year><volume>159</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2011.12.005</pub-id><?supplied-pmid 22197384?><pub-id pub-id-type="pmid">22197384</pub-id>
</element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Djokovic</surname><given-names>N</given-names></name><etal/></person-group><article-title>Expanding the accessible chemical space of SIRT2 inhibitors through exploration of binding pocket dynamics</article-title><source>J. Chem. Inform. Modeling</source><year>2022</year><volume>62</volume><fpage>2571</fpage><lpage>2585</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.2c00241</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Bisson</surname><given-names>WH</given-names></name><name><surname>Maser</surname><given-names>P</given-names></name><name><surname>Scapozza</surname><given-names>L</given-names></name><name><surname>Picard</surname><given-names>D</given-names></name></person-group><article-title>Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors</article-title><source>J. Medicinal Chem.</source><year>2014</year><volume>57</volume><fpage>2524</fpage><lpage>2535</lpage><pub-id pub-id-type="doi">10.1021/jm401801t</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Liang</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group><article-title>Investigating the ibrutinib resistance mechanism of L528W mutation on Bruton&#x02019;s tyrosine kinase via molecular dynamics simulations</article-title><source>J. Mol. Graphics Modelling</source><year>2024</year><volume>126</volume><fpage>108623</fpage><pub-id pub-id-type="doi">10.1016/j.jmgm.2023.108623</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>H</given-names></name><etal/></person-group><article-title>Application of a two-liquid system to sitting-drop vapour-diffusion protein crystallization</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2003</year><volume>59</volume><fpage>194</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1107/S0907444902019741</pub-id><?supplied-pmid 12499569?><pub-id pub-id-type="pmid">12499569</pub-id>
</element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname><given-names>W</given-names></name></person-group><article-title>Xds</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id><?supplied-pmid 20124692?><pub-id pub-id-type="pmid">20124692</pub-id>
</element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonrhein</surname><given-names>C</given-names></name><etal/></person-group><article-title>Data processing and analysis with the autoPROC toolbox</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2011</year><volume>67</volume><fpage>293</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1107/S0907444911007773</pub-id><?supplied-pmid 21460447?><pub-id pub-id-type="pmid">21460447</pub-id>
</element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winn</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Overview of the CCP4 suite and current developments</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2011</year><volume>67</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1107/S0907444910045749</pub-id><?supplied-pmid 21460441?><pub-id pub-id-type="pmid">21460441</pub-id>
</element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagin</surname><given-names>A</given-names></name><name><surname>Teplyakov</surname><given-names>A</given-names></name></person-group><article-title>Molecular replacement with MOLREP</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1107/S0907444909042589</pub-id><?supplied-pmid 20057045?><pub-id pub-id-type="pmid">20057045</pub-id>
</element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>PD</given-names></name><etal/></person-group><article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id><?supplied-pmid 20124702?><pub-id pub-id-type="pmid">20124702</pub-id>
</element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Lohkamp</surname><given-names>B</given-names></name><name><surname>Scott</surname><given-names>WG</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group><article-title>Features and development of Coot</article-title><source>Acta Crystallogr. D: Biol. Crystallogr.</source><year>2010</year><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><?supplied-pmid 20383002?><pub-id pub-id-type="pmid">20383002</pub-id>
</element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pantoliano</surname><given-names>MW</given-names></name><etal/></person-group><article-title>High-density miniaturized thermal shift assays as a general strategy for drug discovery</article-title><source>J. Biomol. Screening</source><year>2001</year><volume>6</volume><fpage>429</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1177/108705710100600609</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>P</given-names></name><etal/></person-group><article-title>Structural basis for specific inhibition of tRNA synthetase by an ATP competitive inhibitor</article-title><source>Chem. Biol.</source><year>2015</year><volume>22</volume><fpage>734</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2015.05.007</pub-id><?supplied-pmid 26074468?><pub-id pub-id-type="pmid">26074468</pub-id>
</element-citation></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">Bowers, K. J. et al. In: <italic>SC &#x02018;06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing</italic> 43&#x02013;43 (Institute of Electrical and Electronics Engineers (IEEE), 2006). 10.1109/SC.2006.54.</mixed-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C</given-names></name><etal/></person-group><article-title>OPLS4: improving force field accuracy on challenging regimes of chemical space</article-title><source>J. Chem. Theory Comput.</source><year>2021</year><volume>17</volume><fpage>4291</fpage><lpage>4300</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.1c00302</pub-id><?supplied-pmid 34096718?><pub-id pub-id-type="pmid">34096718</pub-id>
</element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillan</surname><given-names>MJ</given-names></name><name><surname>Alfe</surname><given-names>D</given-names></name><name><surname>Michaelides</surname><given-names>A</given-names></name></person-group><article-title>Perspective: How good is DFT for water?</article-title><source>J Chem Phys</source><year>2016</year><volume>144</volume><fpage>130901</fpage><pub-id pub-id-type="doi">10.1063/1.4944633</pub-id><?supplied-pmid 27059554?><pub-id pub-id-type="pmid">27059554</pub-id>
</element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>L</given-names></name><etal/></person-group><article-title>A new variant of the colistin resistance gene MCR-1 with co-resistance to beta-lactam antibiotics reveals a potential novel antimicrobial peptide</article-title><source>PLoS Biol.</source><year>2023</year><volume>21</volume><fpage>e3002433</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.3002433</pub-id><?supplied-pmid 38091366?><pub-id pub-id-type="pmid">38091366</pub-id>
</element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><year>2015</year><volume>1-2</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id></element-citation></ref></ref-list></back></article>